3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On September 17, 2026, Angel Studios entered into a Second Amended and Restated merger agreement for its acquisition of Toothy Cow Productions, which revises how Class A Common Stock is allocated among TCP's unitholders. The filing says the net effect is to shift part of the consideration from TCP Common Units to TCP Preferred Units, and that Company related parties, who own 2.3% of TCP units, will also receive shares.
Agreement dated September 17, 2026, amends and restates the June 29, 2026 A&R TCP Merger Agreement in its entirety.
Preferred Reallocation Shares set at 439,127 shares of Buyer Common Stock; Incentive Shares reduced from 516,620 to 77,493 shares.
Company committed up to $11.9 million to fund TCP operations through seasons three and four; $12.6 million provided to date.
If the acquisition is not completed, operational funding converts into TCP Class B Preferred Units at $1.50 per unit plus warrants.
Cullinan Therapeutics announced on October 1, 2026 that it has initiated a New Drug Application submission to the FDA for zipalertinib plus platinum-based chemotherapy in previously untreated EGFR exon 20 insertion NSCLC, under the FDA's Real-Time Oncology Review program. The company expects to complete the submission by year-end 2026, and the filing does not disclose financial results or a change in guidance. For shareholders, this is a regulatory milestone that also keeps milestone payments from partner Taiho in view.
NDA submission initiated on October 1, 2026 under the FDA's Real-Time Oncology Review program; completion expected by year-end 2026
Submission is based on Phase 3 REZILIENT3 trial data, which met its primary endpoint for median progression-free survival
A separate NDA for zipalertinib monotherapy remains under FDA review with a PDUFA target action date of February 27, 2027
Company is eligible for a $30.0 million payment from Taiho on U.S. approval in second-line treatment and up to $100.0 million on first-line approval
Nauticus Robotics entered a Sixth Amendment to its Senior Secured Term Loan Agreement on September 30, 2026, lowering the conversion price on the loans to $1.488 for the period ending October 2, 2026. The loans were originally convertible at an initial price of $6.00, and the company has repeatedly lowered that price through a series of amendments since October 2025, which changes how many common shares the loans could convert into.
Sixth Amendment dated September 30, 2026 reduces the conversion price to $1.488 for the period ending October 2, 2026
Initial conversion price under the term loan was $6.00, subject to adjustment
Fifth Amendments, dated as of September 14, 2026, extended the maturity date to January 31, 2028
Exhibits 10.1 and 10.2 containing the amendment and collateral agent consent were filed with the report
Nauticus Robotics received two waivers from a single holder of its Series B and Series C Convertible Preferred Stock covering a Triggering Event tied to preferred shares remaining outstanding on or after September 30, 2026. The waivers run through March 31, 2027, and waive the default 18% dividend rate, incremental dividends, and the Triggering Event Conversion with its 125% multiplier, for that period only.
Waivers were executed by one holder on September 30, 2026, covering Series B and Series C Preferred Stock separately.
Waiver Period runs from September 30, 2026 through March 31, 2027.
Waived the increase to an 18% per annum default dividend rate and the 125% Conversion Amount multiplier, but not the existing 120% calculation.
Waivers bind only the signing holder; the filing does not waive other triggering events, breaches, or defaults.
Hyliion Holdings adopted a nonqualified deferred compensation plan on September 28, 2026, letting selected managers and non-employee directors defer settlement of equity awards. The plan does not provide for Company contributions, and initial enrollment is expected in December 2026.
Plan approved by the Board on September 28, 2026, on Compensation Committee recommendation
Employees may defer 100% of restricted stock unit and performance share awards; directors may defer 100% of restricted stock unit awards
Plan does not provide for Company contributions; deferred awards settle in Common Stock under the 2024 Equity Incentive Plan
Forward Industries said it added 948,601 SOL in its fiscal fourth quarter ended September 30, 2026, raising holdings 13% to 8,501,298 SOL, with purchases at an average cost of $83 per SOL. SOL per fully diluted share rose to 0.0806 from 0.0730 over the quarter, while net asset value increased to $870.4 million and institutional debt rose to $167.5 million, and the company said part of the purchases was funded by selling FWDI shares. All figures are preliminary and unaudited and remain subject to the company's annual audit.
SOL and SOL equivalents rose by 948,601 (13%) to 8,501,298 as of September 30, 2026, from 7,552,698 on June 30, 2026.
SOL per fully diluted share increased to 0.0806 from 0.0730, quarterly growth of 10.4% or about 42% annualized.
Net asset value was $870,382,702 as of September 30, 2026, up from $481,328,023; institutional debt rose to $167.5 million from $105 million.
Figures are preliminary and unaudited and remain subject to completion of the annual audit.
Axogen, Inc. (Nasdaq: AXGN) said on October 1, 2026 that it completed its previously announced acquisition of privately held BioCircuit Technologies, Inc., maker of the NerveTape sutureless nerve repair device. The company expects BioCircuit to add about $6 million to fourth-quarter 2026 revenue and about $34 million to 2027 revenue, a contribution not included in its full-year 2026 guidance of at least 24% revenue growth. The filing does not disclose the purchase price.
Acquisition of BioCircuit Technologies, Inc. completed; announced October 1, 2026
Expected BioCircuit revenue contribution: about $6 million in Q4 2026 and about $34 million in 2027
Contribution is not included in the existing full-year 2026 guidance of at least 24% revenue growth
Company continues to expect gross margin of at least 73% and positive free cash flow for full-year 2026
Pyxis Oncology closed an underwritten public offering on October 1, 2026, selling 36,047,919 shares and pre-funded warrants for 1,883,121 shares, each paired with common warrants, for a combined price of $2.90 per share. The company expects net proceeds of about $102.8 million, and says its cash plus these proceeds will fund operations into the first half of 2028. The common warrants cannot be exercised until stockholders approve an increase in authorized shares, and if they are exercised, the company would receive about $162.2 million more, net of a 6% solicitation fee.
Offering: 36,047,919 shares and 1,883,121 pre-funded warrants, with common warrants for up to 49,310,352 shares; closed October 1, 2026
Combined public offering price of $2.90 per share; common warrants have a $3.50 exercise price
Net proceeds of about $102.8 million; up to about $162.2 million more if all warrants are exercised, net of a 6% fee
Warrants require a stockholder vote to increase authorized shares, with a meeting planned within 60 days of closing; the company says funds may be insufficient for the Phase 3 Headliner trial if warrants go unexercised
At its virtual annual meeting on October 1, 2026, Aethlon Medical's stockholders elected five directors, approved an increase of 100,000 shares to the 2020 Equity Incentive Plan, and approved a series of other proposals. The filing also shows stockholders approved raising authorized common stock from 20,000,000 to 200,000,000 shares, which could allow future share issuance and dilution for holders of the current 711,136 outstanding shares.
Five directors elected, including Chetan S. Shah, MD and Nicolas Gikakis, each for terms ending at the next annual meeting
Stockholders approved a 100,000-share increase to the 2020 Equity Incentive Plan, effective October 1, 2026
Proposal to increase authorized common shares from 20,000,000 to 200,000,000 passed with 370,879 votes for and 27,208 against
Approximately 56.21% of the 711,136 eligible shares were represented, establishing a quorum
Workday entered a new Credit Agreement on October 1, 2026, replacing its prior $1.0 billion revolving credit facility. The new facility provides up to $1.5 billion in revolving credit, and Workday had no revolving loans outstanding as of that date. The filing describes the facility's pricing, covenants, and maturity, which give Workday a larger committed borrowing source.
New revolving credit facility totals $1.5 billion, up from $1.0 billion under the prior agreement dated April 6, 2022
No revolving loans were outstanding as of October 1, 2026
Facility matures October 1, 2031, with up to two requests to extend by one year
Financial covenant requires a maximum leverage ratio of 3.50 to 1.00, with a step-up to 4.50 to 1.00 after a Qualified Acquisition
Synaptics and onsemi signed an amended and restated merger agreement on October 1, 2026, after an unsolicited competing proposal received September 2, 2026. Synaptics shareholders would receive $123 per share in cash instead of onsemi stock, and the Synaptics board unanimously approved the revised deal. The transaction is expected to close by mid-2027, subject to Synaptics shareholder approval and regulatory approvals.
Merger consideration is $123 per share in cash, without interest; the deal is valued at approximately $5.7 billion, compared with approximately $7 billion under the prior agreement.
The transaction is expected to close by mid-2027, subject to Synaptics shareholder approval, required regulatory approvals and other customary conditions.
The Federal Trade Commission has approved the transaction, and regulators in other jurisdictions are reviewing it; the Hart-Scott-Rodino approval has already been obtained.
onsemi will fund the deal with cash on hand and committed debt financing from Morgan Stanley, and the agreement has no financing condition.
ENDRA Life Sciences amended its June 25, 2026 merger agreement with ASP Isotopes and related parties on October 1, 2026, removing the classified board requirement, revising the minimum cash closing condition to $3,800,002.59 less agreed expenses, and allowing ASP-related lending to Renergen to rise from $80 million to up to $200 million. The company also amended warrants held by an ASP Isotopes affiliate to remove the 4.99% beneficial ownership limit, which changes how that affiliate can exercise them.
Amendment dated October 1, 2026 changes the merger terms, including the minimum cash closing condition of $3,800,002.59, less agreed expenses.
Renergen's ASPI borrowing capacity would rise from $80 million to up to $120 million, then to up to $200 million at or before closing.
Warrant amendments remove the 4.99% beneficial ownership limitation for LHE LNG Holdings, an ASP Isotopes subsidiary.
Warrants covering 324,372 pre-funded shares and all common warrants become exercisable only after stockholder approval.
SKYX Platforms said independent director Efrat L. Greenstein Brayer died on September 26, 2026, leaving the company out of compliance with Nasdaq rules requiring a majority-independent board and an audit committee of at least three members. Nasdaq sent a cure-period letter on September 30, 2026, and the filing says there is no immediate effect on the listing, but the company cannot assure it will regain compliance in time.
Director Efrat L. Greenstein Brayer died on September 26, 2026; she sat on the audit, compensation and nominating committees.
Company notified Nasdaq on September 28, 2026 of non-compliance with Listing Rules 5605(b)(1) and 5605(c)(2)(A).
Nasdaq cure period ends at the earlier of the next annual meeting or September 26, 2027; if that meeting is before March 25, 2027, compliance is due by March 25, 2027.
The filing states there is no immediate effect on the Nasdaq listing, but no assurance was given that compliance will be regained within the cure period.
At its September 29, 2026 annual meeting, Pelthos Therapeutics stockholders approved a new 2026 Equity Incentive Plan that replaces the 2023 plan, and re-elected all eight director nominees. Stockholders also ratified Grant Thornton LLP as the auditor for fiscal 2026. The filing reports votes only and does not disclose financial results.
Stockholders approved the 2026 Equity Incentive Plan, effective immediately, with 2,698,543 for and 187,365 against.
All eight director nominees were elected to serve until the 2027 annual meeting.
Grant Thornton LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2026.
Quorum was met with 3,396,094 votes, or 70.0% of voting power as of the August 4, 2026 record date.
onsemi, Synaptics and Merger Sub signed an Amended and Restated Merger Agreement on October 1, 2026, after Synaptics received an unsolicited proposal from a third party. The revised deal is all-cash at $123 per share, with an aggregate value of about $5.7 billion versus about $7 billion under the prior agreement. onsemi says the transaction is now expected to be immediately accretive to non-GAAP earnings per share upon closing.
Merger consideration revised to $123 per share in cash; aggregate value about $5.7 billion, down from about $7 billion under the June 25, 2026 agreement.
Morgan Stanley Senior Funding, Inc. committed up to $2.45 billion of senior secured term loan under a commitment letter dated October 1, 2026.
onsemi expects the deal to be immediately accretive to non-GAAP EPS; the transaction is expected to close by mid-2027, subject to Synaptics shareholder approval and regulatory approvals.
The Federal Trade Commission has approved the transaction; regulators in other jurisdictions are still reviewing it.
Teads Holding Co. expanded its board from ten to eleven directors and elected Stuart Kovensky, a former co-founder and co-CEO of Onex Credit Partners, to fill the new seat. The filing says he joins the Financing Committee, which the company frames as part of its ongoing capital structure work, and it reports a $40,000 monthly cash retainer for his board service.
Board increased from ten to eleven directors; Kovensky elected effective from the September 29, 2026 board action as a Class I director with a term expiring at the 2028 Annual Meeting
Kovensky appointed to the Financing Committee
Compensation: $40,000 monthly cash retainer, payable in advance, plus $4,000 per day under certain specified circumstances
Board determined Kovensky is independent under Nasdaq rules
Traeger's board appointed David R. Jolley as a director effective October 1, 2026, as a Class III director serving until the 2027 annual meeting. He also joins the audit and compensation committees. The filing covers a board addition, not a change in financial results or guidance.
David R. Jolley appointed to the board effective October 1, 2026, with a term expiring at the 2027 annual meeting
Jolley appointed to the audit committee and compensation committee, effective October 1, 2026
As a non-employee director, he will receive compensation under the Proxy Statement's Director Compensation terms and may join the Deferred Compensation Plan
Veritone, Inc. disclosed a registered direct offering of 20,000,000 shares of its common stock to named purchasers under a securities purchase agreement dated September 30, 2026. The filing attaches a legal opinion from Cooley LLP and does not state the offering price or proceeds, so the dilution and cash impact cannot be determined from this document.
Offering of 20,000,000 shares of common stock at $0.001 par value to named purchasers
Securities purchase agreement entered into September 30, 2026
Made under Form S-3 registration statement No. 333-280148, effective June 21, 2024
Exhibit 5.1 is a Cooley LLP opinion dated October 1, 2026
KBR named Rami Qasem as a director effective October 1, 2026, filling a new board seat for a term ending at its 2027 annual meeting. The Board has deemed him independent, and his committee assignments have not yet been set. The appointment comes ahead of the planned January 2027 spin-off of its Mission Technology Solutions business, which will be called Trinzic.
Rami Qasem, age 59, joins the KBR board effective October 1, 2026, with a term expiring at the 2027 annual meeting.
Qasem previously served as CEO of Digital Solutions at Baker Hughes from 2017 to 2023 and spent 21 years at General Electric.
The Board has determined Qasem is independent; committee assignments will be disclosed later by amendment.
KBR plans to spin off Mission Technology Solutions as Trinzic in January 2027, a business the company says will have more than $5 billion in annual revenue.
Sizzle Acquisition Corp. II and Trasteel Holding S.A. announced that Pubco, a newly formed Luxembourg holding company, confidentially submitted a draft Form F-4 registration statement to the SEC on September 30, 2026, tied to their previously announced business combination agreement. The registration statement has not been filed or declared effective and remains subject to SEC review, so the deal is still pending and its closing is subject to shareholder approval and other conditions.
Draft Form F-4 confidentially submitted to the SEC by Pubco on September 30, 2026; the filing is not yet public or declared effective.
Business combination agreement is dated April 13, 2026, as amended; Pubco would be listed on Nasdaq under the ticker TSTL after closing.
Filing notes Sizzle II must complete the business combination by April 3, 2027 or liquidate and dissolve.
James Hardie Industries plc said its Board appointed Jennifer Kong-Picarello, currently Senior Vice President and Chief Financial Officer of Terex Corporation, as an independent Class III director effective October 1, 2026. She is expected to join the Audit Committee in November 2026. The filing reports no arrangements or transactions requiring disclosure, and she will receive the standard non-employee director compensation.
Effective October 1, 2026, Jennifer Kong-Picarello, 48, joins the Board as an independent Class III director.
Expected to be appointed to the Audit Committee in November 2026.
Currently SVP and CFO of Terex Corporation; previously SVP and CFO of the Energy Management segment of Schneider Electric from 2022 to 2025.
Will receive standard non-employee director compensation and sign the Company's standard Deed of Access, Insurance and Indemnity.
On October 1, 2026, Energy Services of America agreed to buy substantially all operating assets of FAMCO, Inc., a West Virginia water and sewer utility contractor, for a base price of $6.95 million, subject to adjustments. Half the price will be paid in newly issued Energy Services common stock, so the deal would add shares for existing holders, and the company expects closing on or about October 9, 2026. The company says FAMCO's workforce, equipment and contract backlog are expected to complement its existing water and utility construction operations.
Base purchase price of $6.95 million, subject to adjustments in the agreement
Three-eighths paid in cash at closing; one-half in common stock issued after closing; one-eighth withheld pending a post-closing true-up
Buyer is new subsidiary FAMCO Acquisition, Inc.; closing expected on or about October 9, 2026, subject to closing conditions
NexMetals reported an updated Mineral Resource Estimate for Selebi Main, one deposit at its past-producing Botswana copper-nickel-cobalt mine, with 32.47 million tonnes in the Inferred category, up 72% from the Selebi Main portion of its 2024 estimate. The Selebi North estimate is still in progress and is not included, and the filing says the resource is not a mineral reserve and may never be mined economically.
Selebi Main tonnage rose to 32.47 million tonnes, grading 1.53% copper and 0.97% nickel, versus 18.89 million tonnes in the 2024 estimate.
Contained copper increased 55% to 495,400 tonnes and contained nickel increased 91% to 316,800 tonnes; cobalt is now included.
The company reported approximately $10.5 million in cash at September 30, 2026.
A NI 43-101 Technical Report is to be filed within 45 days of the October 1, 2026 release.
Nexalin Technology received Nasdaq confirmation on September 30, 2026 that it has regained compliance with the $1.00 minimum bid price requirement. The company still must show at least $2,500,000 in stockholders' equity by January 4, 2027, or its stock faces delisting from Nasdaq.
Nasdaq confirmed on September 30, 2026 that the bid price requirement of $1.00 per share is met
Remaining condition: stockholders' equity of at least $2,500,000 by January 4, 2027
The company says it intends to meet the equity requirement, but gives no assurance it will
Nexalin Technology entered a 10-year exclusive distribution agreement, effective September 22, 2026, with Inovanexa Medical Technologies S.A. for its Nexalin Sync device in seven countries. The filing discloses no purchase value or revenue figures, and the company says it is pre-revenue, so the financial effect for shareholders depends on purchase orders and the performance requirements that the distributor must meet.
Exclusivity covers Brazil, Argentina, Chile, Uruguay, Paraguay, Ecuador and Venezuela, with a 10-year initial term that renews automatically if performance requirements are met.
The 8-K says the distributor must place an initial binding order for five devices at signing, with a clinical pilot targeted within 90 days. The press release says the binding order is for 10 devices, with five delivered immediately.
After the first 30 devices are purchased, the distributor must set up a local manufacturing facility in Brazil at its own cost, and Nexalin would receive per-device compensation and disposable royalties.
The filing states the distributor is not otherwise obligated to buy more devices, and the company's risk disclosures say it may never recognize revenue beyond the initial order.
Eagle Bancorp Montana, Inc. approved amendments to supplemental retirement (salary continuation) agreements for CEO Laura F. Clark and CFO Miranda J. Spaulding, and a new agreement for President and COO P. Darryl Rensmon, all dated September 28, 2026. The filing shows higher annual retirement benefits for these executives, which increase the company's future compensation obligations.
Clark's annual benefit rises from $46,000 to $86,500 if her separation from service occurs on or after May 1, 2027, effective October 1, 2026.
Spaulding's annual benefit rises from $99,500 to $136,500, effective October 1, 2026.
Rensmon's new agreement provides a fixed retirement benefit of $47,500 annually, payable for life upon termination at age 70.
Two indirect subsidiaries of SharonAI Holdings signed a $356 million senior secured term loan facility on September 28, 2026, to finance GPU servers and data center infrastructure for a customer contract. The parent company guarantees the loans on a limited, releasable basis, and the filing says the financing becomes non-recourse to the parent after Facility A is repaid. Shareholders should note the debt carries fixed interest rates of 7.25% to 9.95% and a 42-month maturity, with a change of control and customer contract default treated as review events.
Facilities total up to US$356 million: Facility A up to US$150 million and Facility B up to US$206 million.
Facility A bears an initial 7.25% fixed rate that rises to as high as 9.95%; Facility B bears a fixed 9.95% rate.
Each facility matures 42 months after first utilization, and the Company guarantees the Borrowers' payment obligations through a releasable guarantee deed poll.
The press release says Jarden Australia was sole financial advisor and arranger, and names Goldman Sachs among the investors.
Modine completed the spin-off and combination of its Performance Technologies business with Gentherm in a Reverse Morris Trust transaction on October 1, 2026. Modine received a cash distribution of approximately $156 million, used to repay debt, and shareholders received 0.44619 Gentherm shares per Modine share, with Modine shareholders owning about 43.62% of the combined company.
Modine received a cash distribution of approximately $156 million, used to prepay borrowings under its credit agreement with JPMorgan Chase Bank, N.A. as administrative agent.
Modine shareholders received 0.44619 Gentherm shares for each Modine share held at the close of business on September 28, 2026.
The transaction valued the Performance Technologies business at approximately $946.4 million, based on Gentherm's closing price on September 30, 2026.
Modine plans a special shareholder meeting within three months to vote on renaming the company Modexus Solutions; the ticker MOD is expected to remain unchanged.
Achieve Life Sciences said its board appointed Benjamin Halladay as Chief Financial Officer effective October 5, 2026, replacing Mark Oki, who is stepping down from the role on the same date. Mr. Halladay previously served as CFO of Esperion Therapeutics from November 2022 until September 2026, and the company said Mr. Oki's departure is not related to any disagreement over its financial statements or disclosures.
Benjamin Halladay appointed CFO and principal financial officer, effective October 5, 2026
Mark Oki steps down as CFO effective October 5, 2026; the company says there was no disagreement over financial statements or disclosures
Halladay offer letter includes $525,000 base salary, bonus of up to 40% of base salary, option for up to 200,000 shares and 200,000 restricted stock units
Full employment agreement text to be filed with the Form 10-Q for the quarter ending September 30, 2026
PBF Holding Company, a subsidiary of PBF Energy, entered into an amended and restated asset-based revolving credit agreement on September 30, 2026, with Bank of America as administrative agent. The facility replaces the existing agreement dated August 23, 2023, and offers a maximum commitment of $4.0 billion. The filing says the new facility carries reduced commitment fees on unused amounts, while interest rates and letter of credit fees are generally consistent with the prior agreement.
Maximum commitment of $4.0 billion under the 2026 Revolving Loan
Maturity date of September 30, 2031
Reduced commitment fees on the unused portion compared with the Existing Credit Agreement
Interest rates and letter of credit fees generally consistent with the prior agreement
Gentherm completed its combination with Modine's Performance Technologies business on October 1, 2026, in a Reverse Morris Trust transaction. Modine shareholders own about 43.62% of the combined company, and Gentherm shareholders own about 56.38%. The filing also discloses a $250.0 million term loan, guaranteed by Gentherm and secured by substantially all of its assets, plus a $2.07 per share special dividend payable October 7, 2026.
Modine shareholders received 0.44619 Gentherm shares for each Modine share held at the September 28, 2026 record date, with cash in lieu of fractional shares.
Gentherm declared a special dividend of $2.07 per share, payable October 7, 2026 to shareholders of record as of September 28, 2026.
SpinCo borrowed $250.0 million of term loans under a senior secured delayed draw facility with Bank of America, N.A. as administrative agent; Gentherm guarantees the obligations.
Paul Mascarenas was appointed to the board effective October 1, 2026, increasing its size from 9 to 10 members; Katrin Schatz was named Interim President of Modine Performance Technologies.
On October 1, 2026, subsidiary 5E SVM completed its purchase of real property, production facilities, brine resources and other assets from Searles Valley Minerals and related sellers. Consideration included about $3.4 million in cash, 8.3 million common shares and a $6.2 million promissory note, and 5E SVM also took a $10.0 million senior secured bridge loan from Karnavati Holdings, of which $7.0 million was funded at closing. The deal adds assets and debt and increases the share count, which shareholders will want to track.
Consideration: about $3.4 million cash (including a prior deposit), 8.3 million common shares (including 312,500 shares due later upon conditions) and a $6.2 million senior unsecured promissory note.
Promissory note accrues 14.5% annual interest, paid in kind; requires a cash payment of about $1.2 million at the 24-month anniversary and matures on the fifth anniversary.
$10.0 million senior secured bridge facility with Karnavati Holdings, 8.00% interest paid in kind, $7.0 million funded at closing, matures 270 days after closing with a $1.0 million fee.
Shares outstanding after closing: 49,634,871. Company expects $15.7 million cash as of September 30, 2026; the filing gives post-transaction cash as $19.6 with no unit, and Q3 results are preliminary.
On September 29, 2026, Akari Therapeutics amended the Chief Executive Officer Agreement with CEO Abizer Gaslightwala. The amendment raises his base salary from $475,000 to $625,000 effective August 18, 2026, increases his target bonus to 55% of base salary, and grants options on 174,000 ADSs, with parts of the package tied to shareholder approval of a plan amendment.
Base salary rises from $475,000 to $625,000, effective August 18, 2026; $62,500 of it is delivered as RSUs instead of cash over 12 months
Target annual bonus increases from 50% to 55% of base salary, for target base salary and bonus of approximately $970,000
Options to purchase 174,000 ADSs granted as of August 18, 2026, vesting monthly over four years from March 18, 2026
RSUs and option grants depend on shareholder approval of an increase to the ADSs reserved under the 2023 Plan
American Battery Technology Company received approval from the U.S. Department of Commerce's Bureau of Industry and Security for a license to export recycled black mass, allowing sales of up to $100 million under specified terms. The license follows newly enacted federal export controls on critical battery materials, and the company says it supports current operations and its market position.
BIS approved a license allowing sales of up to $100 million of recycled black mass material
The approval follows the implementation of recently enacted federal export controls on critical battery materials
The press release, dated October 1, 2026, cites over 400% year-over-year revenue growth and references the company's fiscal year 2026 results
The filing is a Form 8-K under Item 8.01 with the press release attached as Exhibit 99.1
National Bank Holdings said its bank subsidiary expects material impairments on specific commercial loans, mainly in the franchise and healthcare industries, plus a $4.0 million impairment on a FinTech partnership investment. The charges are expected to reduce after-tax earnings by $32.0 million to $34.0 million, or $0.72 to $0.76 per diluted share, for the third quarter and nine months ended September 30, 2026. Separately, the board approved an additional $40.1 million share repurchase authorization, bringing total repurchase authority to $100.0 million.
Loans with $65.0 million aggregate outstanding principal will be reserved or charged down to an estimated $18.2 million, with estimated charge-offs of $46.8 million.
Provision expense is expected to be $38.0 million to $40.0 million for the three months ended September 30, 2026.
A $4.0 million impairment on one FinTech partnership investment will reduce non-interest income for the quarter.
On September 30, 2026, the board approved a $40.1 million buyback, bringing total authority to $100.0 million; 44,285,618 Class A shares were outstanding at quarter end.
Quaker Chemical entered into an amendment to its credit agreement on October 1, 2026, creating a new $550 million seven-year term loan B facility. Proceeds will repay in full the U.S. Term Loans outstanding under the existing agreement, and the company said the deal extends its debt maturity profile and reduces required annual debt payments.
$550 million term loan B facility matures October 1, 2033
Interest at Term SOFR plus 1.750% for Term SOFR loans; quarterly amortization of 0.25% of initial principal
Proceeds repay in full the U.S. Term Loans; their aggregate principal balance is $0 as of the amendment's effective date
Facility is secured by first priority liens on substantially all assets and carries a 1.00% prepayment premium for a repricing event within six months
Accelevation Holdings Corp. completed its initial public offering of Class A common stock, with the company selling 10,000,000 shares and selling stockholders selling 20,000,000 shares at $18.00 per share, closing on October 1, 2026. The filing also reports seven new directors, amended charter and bylaws, and new agreements governing the company's structure, which shape how existing owners and new public shareholders are related.
Firm offering: 10,000,000 shares sold by the company and 20,000,000 by selling stockholders at $18.00 per share; underwriters hold a 30-day option for up to 4,500,000 more shares
Seven directors appointed September 29, 2026, including Manu Bettegowda, Matt Bujor and Michael Rubiera-linked director nomination rights
Amended and restated certificate of incorporation and bylaws effective September 29, 2026; 116,965,529 Class B shares issued to Investment Holdings
Goodyear's vice president and controller, Margaret V. Snyder, is resigning effective October 16, 2026 to pursue another opportunity, and the company says the departure is unrelated to its financial or operating results. Stephen F. Shamrock, previously vice president and assistant controller, will take the controller role and serve as principal accounting officer, following the company's established succession plan.
Margaret V. Snyder resigns as Vice President and Controller effective October 16, 2026
Stephen F. Shamrock named Vice President and Controller effective October 16, 2026
Shamrock, 54, rejoined Goodyear September 24, 2025; previously held controller and CFO roles at Nordson and Materion
Goodyear expects to review Shamrock's compensation in October 2026
Vertex, Inc. said its Board elected Debanjan Saha, CEO of DataRobot since September 2022, as a Class II director effective October 7, 2026. The Board determined he is independent, and he has not yet been named to any Board committee.
Saha elected September 30, 2026 as Class II director, term expiring at the 2028 Annual Meeting of Stockholders
Saha is CEO of DataRobot, an agentic AI company, and previously held roles at Google Cloud and Amazon Web Services
He will receive a pro-rated annual restricted stock award and sign the company's standard indemnification agreement
Filing reports no financial results, and no committee assignments have been made
Fortress Biotech repaid in full the remaining $15.0 million of principal on its Oaktree senior secured credit facility on September 30, 2026, plus about $435,000 of accrued interest, a $150,000 prepayment fee and other closing costs. With the repayment, the debt is satisfied, liens on company property are released, and the Oaktree Agreement terminated automatically.
Principal repaid: $15.0 million on September 30, 2026, with the facility originally a $50.0 million senior secured credit agreement dated July 25, 2024
Additional payments: about $435,000 in accrued interest and a $150,000 prepayment fee, plus other closing costs
Upon repayment, all liens securing the facility were released and the Oaktree Agreement terminated
Cardinal Infrastructure Group completed its acquisition of Allied Paving Contractors on October 1, 2026, for approximately $115.0 million, paid in cash and 1,006,796 newly issued Class A shares, subject to customary post-closing adjustments. The deal expands Cardinal's self-performed paving work in the Atlanta market, and Allied generated approximately $100 million in standalone revenue, though part of that volume will be performed on Cardinal projects and reflected in margin rather than consolidated revenue. Shareholders will see the share issuance dilute their holdings slightly, and the filing gives no profit or earnings figures for Allied.
Acquisition of Allied Paving Contractors closed October 1, 2026, for approximately $115.0 million in total consideration
Consideration included approximately $88.9 in cash and 1,006,796 Class A Common Stock shares, issued without registration under Section 4(a)(2)
Allied generated approximately $100 million in revenue on a standalone basis
Allied CEO John McLean will join Cardinal's leadership team to manage paving operations across Georgia
NextDecade Corporation disclosed that director Giovanni Oddo resigned from its Board of Directors, effective immediately, by letter dated September 29, 2026. Mr. Oddo said the resignation was not due to any disagreement with the company on its operations, policies or practices. Under the Purchaser Rights Agreement, NIC, an affiliate of Mubadala Investment Company, may designate a replacement.
Resignation letter received September 29, 2026; effective immediately
Mr. Oddo was first appointed to the board in May 2022 under the Purchaser Rights Agreement dated October 28, 2019
Resignation not due to any disagreement on operations, policies or practices, per Mr. Oddo
NIC, an affiliate of Mubadala Investment Company, has the right to name a replacement director
EastGroup Properties appointed Bethany Logan Ropa and Robyn R. Werner as independent directors effective October 1, 2026, increasing the board from seven to nine members. The filing says committee assignments have not yet been set and describes director pay and indemnification terms, which affect the company's governance and costs.
Board increased from seven to nine directors; Ropa and Werner appointed effective October 1, 2026
Ropa is CFO of JE Dunn Construction Group; previously a UBS real estate investment banking managing director from 2008 to 2025
Werner is a retired Ernst & Young assurance partner (2008 to 2025) and a Certified Public Accountant
Non-employee directors receive a $80,000 annual cash retainer and $145,000 annual restricted stock grant, plus a $25,000 initial restricted stock grant
Digital Turbine filed a resale prospectus supplement under its universal shelf registration on October 1, 2026, covering 1,222,418 common shares that selling stockholders may sell from time to time. The company said the filing provides a legal opinion on the validity of those securities, and it does not state that the company itself will sell any shares or receive proceeds.
Prospectus supplement covers 1,222,418 shares of common stock, par value $0.0001 per share, held by listed selling stockholders
Filed October 1, 2026 under Form S-3ASR (File No. 333-299236) and Rule 424(b)(7)
Exhibit 5.1 is a legal opinion from Jackson Walker L.L.P. on the validity of the securities
SmartStop Self Storage REIT declared its October 2026 monthly common stock dividend on October 1, 2026, reflecting a targeted annualized dividend of $1.60 per share. The filing is a routine monthly declaration with a record date of October 30, 2026 and a payment date of November 13, 2026.
Monthly dividend of $0.13589041 per common share for October 2026
Targeted annualized dividend of $1.60 per share
Record date: October 30, 2026; payment date: November 13, 2026
Goodyear approved a plan on September 29, 2026 to close its chemical manufacturing facilities in Niagara Falls, New York and Bayport, Texas, affecting about 85 jobs. The company estimates total pre-tax charges of $55 million to $75 million, with about $30 million in cash charges, and expects the plan to improve Americas segment operating income by $15 million to $20 million annually starting in 2027.
Plant closures: Niagara Falls, New York and Bayport, Texas; about 85 job reductions
Estimated pre-tax charges of $55 million to $75 million, of which about $30 million are cash charges
Approximately $35 million of charges expected in Q3 2026 and $15 million in the rest of 2026
Expected annual Americas operating income benefit of $15 million to $20 million beginning in 2027
On September 25, 2026, an indirect subsidiary of Ashford Hospitality Trust completed the sale of the 220-room Embassy Suites Las Vegas for about $42.7 million in cash, net of selling expenses. The company paid about $41.2 million of the proceeds to the mortgage lender, and the filing's pro forma figures show the sale would have reduced the 2025 net loss to common stockholders, mainly through a preliminary non-recurring gain.
Sale completed September 25, 2026, under an agreement dated August 27, 2026, with buyer 4315 Hospitality LLC
Net cash consideration of about $42.7 million; about $41.2 million paid to the mortgage lender, which is also secured by seven other hotels
Pro forma 2025 net loss attributable to common stockholders of $184.3 million, versus $215.0 million as reported; the pro forma gain is preliminary
Horizon Bancorp (HBNC) said it will release its third quarter 2026 results after the market close on Wednesday, October 21, 2026, and host a conference call on Thursday, October 22, 2026 at 7:30 a.m. CT. The filing is a scheduling notice and contains no financial results, so it does not change the company's reported performance.
Third quarter 2026 results release: after market close, Wednesday, October 21, 2026
Conference call: Thursday, October 22, 2026 at 7:30 a.m. CT (8:30 a.m. ET)
Replay available through November 22, 2026; press release attached as Exhibit 99.1
Company reported $6.6 billion in assets as of June 30, 2026
H2O America said its Texas subsidiary completed the purchase of substantially all assets of Quadvest's water and sewer utility businesses on October 1, 2026, for a base price of $540 million, subject to customary adjustments. The company says the deal more than doubles its Texas water and wastewater connections and expects Texas to represent 26% of its customer base by 2029, up from 8%.
Base purchase price of $540 million, subject to customary purchase price adjustments
Deal covers the regulated and wholesale water and sewer businesses of Quadvest, with closing on October 1, 2026
H2O America expects Texas to be 26% of its customer base by 2029, versus 8% before October 1
Financial statements and pro forma information will be filed by amendment later
Pebblebrook Hotel Trust said Bill Bayless joined its Board of Trustees on October 1, 2026, increasing the board from seven to eight members. Bayless is CEO of Maslow Campus Communities and co-founded American Campus Communities, and he will receive the same trustee fees and a $50,000 share award as the company's other independent trustees.
Bayless joined the board on October 1, 2026; the board was previously elected to appoint him on February 5, 2026, and he will serve until the 2027 annual meeting.
He received a one-time $50,000 award in common shares, vesting in one-third increments annually over three years.
The company entered into an indemnification agreement with Bayless on October 1, 2026, on the same terms as its other trustees and executive officers.
Bayless has been involved in nearly $30 billion in real estate transactions over his career of more than 35 years.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.